Nantahala Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,859
| Closed | -$280K | – | 116 |
|
|
2020
Q2 | $280K | Buy |
+4,859
| New | +$280K | 0.01% | 94 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 101 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 86 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 90 |
|
|
2019
Q1 | – | Sell |
-623,338
| Closed | -$6.8M | – | 94 |
|
|
2018
Q4 | $6.8M | Sell |
623,338
-20,000
| -3% | -$218K | 0.21% | 49 |
|
|
2018
Q3 | $8.13M | Buy |
643,338
+28,165
| +5% | +$356K | 0.22% | 43 |
|
|
2018
Q2 | $8.1M | Buy |
615,173
+14,685
| +2% | +$193K | 0.33% | 38 |
|
|
2018
Q1 | $8.17M | Sell |
600,488
-344,586
| -36% | -$4.69M | 0.37% | 33 |
|
|
2017
Q4 | $5.62M | Buy |
945,074
+267,295
| +39% | +$1.59M | 0.25% | 32 |
|
|
2017
Q3 | $5.03M | Buy |
677,779
+72,426
| +12% | +$537K | 0.25% | 28 |
|
|
2017
Q2 | $5.67M | Hold |
605,353
| – | – | 0.45% | 26 |
|
|
2017
Q1 | $4.41M | Buy |
605,353
+137,898
| +29% | +$1M | 0.49% | 28 |
|
|
2016
Q4 | $3.46M | Buy |
467,455
+1,015
| +0.2% | +$7.51K | 0.36% | 33 |
|
|
2016
Q3 | $2.82M | Buy |
466,440
+37,753
| +9% | +$228K | 0.34% | 38 |
|
|
2016
Q2 | $1.93M | Buy |
+428,687
| New | +$1.93M | 0.21% | 47 |
|